{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Dr. Reddy\u2019s Q1 FY24 Financial Results - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"kVXfxAtJiV\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-q1-fy24-financial-results\/\">Dr. Reddy\u2019s Q1 FY24 Financial Results<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/dr-reddys-q1-fy24-financial-results\/embed\/#?secret=kVXfxAtJiV\" width=\"600\" height=\"338\" title=\"&#8220;Dr. Reddy\u2019s Q1 FY24 Financial Results&#8221; &#8212; Market Newsdesk\" data-secret=\"kVXfxAtJiV\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Dr. Reddy\u2019s Q1 FY24 Financial Results HYDERABAD, India&#8211;(BUSINESS WIRE)&#8211; Dr. Reddy\u2019s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter ended June 30, 2023. The information mentioned in this release is based on consolidated financial statements under International Financial Reporting Standards (IFRS). Revenues Rs. 67,384 Mn \u00a0 [Up: 29%* YoY; Up: 7%* QoQ] \u00a0 \u00a0 Gross Margin 58.7% \u00a0 [Q1 FY23: 49.9%; Q4 FY23: 57.2%] \u00a0 \u00a0 SG&amp;A Expenses Rs. 17,702 Mn \u00a0 [Up: 14% YoY; Down: 2% QoQ] \u00a0 R&amp;D Expenses Rs. 4,984 Mn [7.4% of Revenues] \u00a0 \u00a0 EBITDA Rs. 21,372 Mn \u00a0 [31.7% of Revenues] \u00a0 \u00a0 Profit before Tax Rs. 18,463 Mn \u00a0 &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230726055989r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"}